Differential use of available genetic tests among primary care physicians in the United States: results of a national survey

被引:110
作者
Shields, Alexandra E. [1 ,2 ,3 ]
Burke, Wylie [4 ]
Levy, Douglas E. [1 ,2 ,3 ]
机构
[1] Massachusetts Gen Hosp, Ctr Genom Vulnerable Populat & Hlth Disparities, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Inst Hlth Policy, Boston, MA 02114 USA
[3] Harvard Univ, Sch Med, Dept Med, Boston, MA USA
[4] Univ Washington, Dept Med Hist & Eth, Seattle, WA 98195 USA
关键词
physicians; genomics; genetic screening; clinical integration; new technologies;
D O I
10.1097/GIM.0b013e3181770184
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Purpose: This study assesses primary care physicians' experience ordering and referring patients for genetic testing, and whether minority-serving physicians are less likely than those serving fewer minorities to offer such services. Methods: Survey of a random sample of 2000 primary care physicians in the United States (n = 1120, 62.3% response rate based on eligible respondents) conducted in 2002 to assess what proportion have (1) ever ordered a genetic test in general or for select conditions; (2) ever referred a patient for genetic testing to a genetics center or counselor, a specialist, a clinical research trial, or to any site of care. Results: Nationally, 60% of primary care physicians have ordered a genetic test and 74% have referred a patient for genetic testing. Approximately 62% of physicians have referred a patient for genetic testing to a genetics center/counselor or to a specialist, and 17% to a clinical trial. Minority-serving physicians were significantly less likely to have ever ordered a genetic test for breast cancer, colorectal cancer, or Huntington disease, or to have ever referred a patient for genetic testing relative to those serving fewer minorities. Conclusions: Reduced utilization of genetic tests/referrals among minority-serving physicians emphasizes the importance of tracking the diffusion of genomic medicine and assessing the potential impact on health disparities.
引用
收藏
页码:404 / 414
页数:11
相关论文
共 49 条
[1]  
*AM COLL OBST GYN, 2000, GEN SCREEN HEM ACOG
[2]  
*AM COLL OBST GYN, 2004, 298 ACOG COMM
[3]  
*AM MED ASS, 2002, AMA MAST
[4]  
[Anonymous], 1996, GUID CLIN PREV SERV
[5]   Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer [J].
Armstrong, K ;
Micco, E ;
Carney, A ;
Stopfer, J ;
Putt, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (14) :1729-1736
[6]   Primary care physicians who treat blacks and whites [J].
Bach, PB ;
Pham, HH ;
Schrag, D ;
Tate, RC ;
Hargraves, JL .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (06) :575-584
[7]   Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility:: Recommendation statement [J].
Berg, AO ;
Allan, JD ;
Calonge, N ;
Frame, PS ;
Gordis, L ;
Gregory, KD ;
Harris, R ;
Johnson, MS ;
Klein, JD ;
Loveland-Cherry, C ;
Moyer, VA ;
Ockene, JK ;
Petitti, DB ;
Siu, AL ;
Teutsch, SM ;
Yawn, BP .
ANNALS OF INTERNAL MEDICINE, 2005, 143 (05) :355-361
[8]  
Blumenthal D, 1999, J FAM PRACTICE, V48, P264
[9]  
Blumenthal D, 2006, HLTH INFORM TECHNOLO
[10]   VARIATIONS IN THE USE OF MEDICATION FOR THE TREATMENT OF CHILDHOOD ASTHMA IN THE MICHIGAN MEDICAID POPULATION, 1980 TO 1986 [J].
BOSCO, LA ;
GERSTMAN, BB ;
TOMITA, DK .
CHEST, 1993, 104 (06) :1727-1733